mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |